Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Walgreens shares slide for fourth day amid mixed market performance

EditorHari Govind
Published 2023-11-02, 07:58 a/m
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect

Walgreens Boots Alliance Inc. (NASDAQ:WBA) shares saw a fourth consecutive day of losses on Wednesday, dropping 2.13% to $20.63, even as major market indices reported gains. The S&P 500 Index and Dow Jones Industrial Average rose by 1.05% and 0.67% respectively, indicating a contrasting performance.

In the broader market, Walgreens' competitors had mixed results. Amazon.com Inc. (NASDAQ:AMZN) saw its stock climb 2.94% to $137.00, while McKesson Corp. (NYSE:NYSE:MCK) increased by 0.93% to $459.59. CVS Health Corp. (NYSE:NYSE:CVS), however, fell slightly by 0.41% to $68.73.

Despite the overall market uptrend, Walgreens' share price remains significantly below its peak of $42.29 recorded on December 13th, reflecting a challenging period for the company in recent months.

Adding to the concerns, Walgreens' trading volume on Wednesday reached 16 million, surpassing its 50-day average volume, a sign that investors may be reacting to the company's recent performance and adjusting their holdings accordingly.

InvestingPro Insights

InvestingPro data provides an insightful view of Walgreens Boots Alliance Inc. (WBA). With a market cap of 17.82B USD, the company has shown promising signs with a revenue growth of 4.81% over the last twelve months as of Q4 2023. Despite trading near its 52-week low, the company has a history of consistent dividend payments, having raised its dividend for 48 consecutive years and offering a substantial dividend yield of 9.31% as of December 2023.

InvestingPro Tips highlight that Walgreens is a prominent player in the Consumer Staples Distribution & Retail industry. Its net income is expected to grow this year, indicating potential for future profitability. However, the stock has taken a significant hit over the last six months. It's worth noting that six analysts have revised their earnings downwards for the upcoming period, which could be a factor contributing to its recent performance.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro offers an additional 8 tips and a wealth of other data for Walgreens, as well as real-time metrics and expert advice for a variety of other companies. This valuable information can help investors make informed decisions about their portfolio.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.